Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab Therapy
Clinical trial NCT02968303 · UNKNOWN
Trial details
- NCT number
- NCT02968303
- Sponsor
- Radboud University Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-27
- Primary completion
- 2022-10-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.